Serum lipids and lipoproteins in women with polycystic ovarian disease with different body mass index
- 1 December 1988
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 27 (3) , 401-406
- https://doi.org/10.1016/0020-7292(88)90121-x
Abstract
A study to determine serum lipids and lipoproteins in 54 women with polycystic ovarian disease (PCOD) who had varying body mass index (BMI) compared to the normal regular menstruating women was carried out. All patients had similar hormonal profiles of PCOD and differed from the control group. The significant observations were high level of triglyceride and low percentage of alpha lipoprotein in obese PCOD. The BMI was positively correlated with serum triglyceride level, beta and prebeta lipoproteins but inversely correlated with high density lipoprotein (HDL) cholesterol, the low density lipoprotein (LDL) cholesterol/HDL cholesterol ratio and alpha lipoprotein. No significant correlation between lipids, lipoproteins and testosterone levels was observed. It appeared that the alteration of serum lipids and lipoproteins in PCOD is due to the effect of obesity.This publication has 19 references indexed in Scilit:
- Lipoprotein Lipid Concentrations and Cardiovascular Risk in Women with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 1985
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart diseaseFertility and Sterility, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal FemalesJournal of Clinical Endocrinology & Metabolism, 1983
- Effect of Estrogen/Progestin Potency on Lipid/Lipoprotein CholesterolNew England Journal of Medicine, 1983
- High Density Lipoprotein-2 and Hepatic Lipase: Reciprocal Changes Produced by Estrogen and Norgestrel*Journal of Clinical Endocrinology & Metabolism, 1982
- The Clinical Significance of the Plasma High Density LipoproteinsMedical Clinics of North America, 1982
- REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROMEClinical Endocrinology, 1980
- Effect of androgens on serum lipids and lipoproteinsLipids, 1972